ERBB2 and neoplasm: The current study indicates that there is a significant association between high CDCA5 and aggressive tumor features including larger tumor size, high tumor grade, LVI positivity, hormonal receptor negativity, HER2 positivity and independent prognostic factor for worse patient outcomes.